The global DNA Sequencing and Next-Generation Sequencing market size was valued at USD 26.29 billion in 2025 and is expected to reach USD 95.19 billion by 2033, at a CAGR of 17.45% during the forecast period
The market growth is largely fueled by rapid advancements in genomic technologies, increasing adoption of personalized medicine, and growing applications of DNA sequencing in diagnostics, drug discovery, and research, leading to higher demand for next-generation sequencing (NGS) solutions
Furthermore, rising investments in genomics research, expanding applications in clinical diagnostics, oncology, and infectious disease testing, and the growing need for high-throughput, cost-effective, and accurate sequencing solutions are accelerating the uptake of DNA Sequencing and NGS technologies, thereby significantly boosting market growth